Skip Header

 
Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q13428 (TCOF_HUMAN)

Last modified July 7, 2009. Version 86. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Treacle protein
Alternative name(s):
    Treacher Collins syndrome protein
Gene names
Name: TCOF1
OrganismHomo sapiens (Human) [Complete proteome]
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length1488 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

May be involved in nucleolar-cytoplasmic transport. May play a fundamental role in early embryonic development, particularly in development of the craniofacial complex By similarity.

Subcellular location

Nucleusnucleolus Potential.

Post-translational modification

Phosphorylated upon DNA damage, probably by ATM or ATR. Ref.6 Ref.7 Ref.8 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15

Involvement in disease

Defects in TCOF1 are the cause of Treacher Collins syndrome (TCS) [MIM:154500]. TCS is an autosomal dominant disorder of craniofacial development that occurs with an incidence of 1/50,000 live births. The clinical features of TCS are bilaterally symmetrical and include: (1) abnormalities of the external ears, atresia of the external ear canals, and malformation of the middle ear ossicles, which may result in conductive hearing loss; (2) lateral downward sloping of palpebral fissures, frequently with colobomas of the lower eyelids; (3) hypoplasia of the mandible and zygomatic complex; (4) cleft palate. Ref.16

Sequence similarities

Contains 1 LisH domain.

Ontologies

Keywords
   Biological processTransport
   Cellular componentNucleus
   Coding sequence diversityAlternative splicing
Polymorphism
   DiseaseDisease mutation
   PTMPhosphoprotein
   Technical termComplete proteome
Gene Ontology (GO)
   Biological processskeletal system development Ref.3

Traceable author statement. Source: ProtInc

transport

Inferred from electronic annotation. Source: UniProtKB-KW

   Cellular componentnucleolus Ref.3

Inferred from direct assay. Source: MGI

   Molecular functionprotein binding

Inferred from physical interaction. Source: IntAct

transporter activity Ref.3

Traceable author statement. Source: ProtInc

Complete GO annotation...

Binary interactions

With

Entry

#Exp.

IntAct

Notes

ARRB1P494072EBI-396105,EBI-743313
ARRB2P321212EBI-396105,EBI-714559

Alternative products

This entry describes 5 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: Q13428-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Note: Major.
Isoform 2 (identifier: Q13428-2)

The sequence of this isoform differs from the canonical sequence as follows:
     214-290: Missing.
     1172-1172: L → LV
Isoform 3 (identifier: Q13428-3)

The sequence of this isoform differs from the canonical sequence as follows:
     1172-1172: L → LV
Isoform 4 (identifier: Q13428-4)

The sequence of this isoform differs from the canonical sequence as follows:
     953-953: Q → QDSNSKPARSKTLAPAPPERNTEGSSESSEEELPLTQ
Note: Minor.
Isoform 5 (identifier: Q13428-5)

The sequence of this isoform differs from the canonical sequence as follows:
     954-958: VIKPP → DQESS
     959-1488: Missing.
Note: No experimental confirmation available.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 14881488Treacle protein
PRO_0000072459

Regions

Domain6 – 3833LisH
Compositional bias89 – 979Poly-Glu
Compositional bias204 – 2074Poly-Ser
Compositional bias693 – 6964Poly-Ser
Compositional bias996 – 10016Poly-Ser
Compositional bias1362 – 13665Poly-Lys
Compositional bias1452 – 146312Poly-Lys
Compositional bias1475 – 14828Poly-Lys

Amino acid modifications

Modified residue831Phosphoserine Ref.7 Ref.15
Modified residue841Phosphothreonine Ref.7 Ref.15
Modified residue851Phosphoserine Ref.7 Ref.15
Modified residue871Phosphoserine Ref.7 Ref.15
Modified residue881Phosphoserine Ref.7 Ref.15
Modified residue1381Phosphoserine Ref.10
Modified residue1441Phosphothreonine Ref.10
Modified residue1531Phosphoserine Ref.10 Ref.12 Ref.15
Modified residue1561Phosphoserine Ref.9 Ref.12 Ref.15
Modified residue1601Phosphoserine Ref.10
Modified residue1641Phosphoserine Ref.7
Modified residue1711Phosphoserine Ref.7
Modified residue1731Phosphothreonine By similarity
Modified residue2331Phosphoserine Ref.7
Modified residue2491Phosphothreonine Ref.8 Ref.15
Modified residue3041Phosphoserine Ref.9
Modified residue3101Phosphothreonine Ref.9 Ref.15
Modified residue3161Phosphothreonine Ref.9 Ref.15
Modified residue3391Phosphoserine By similarity
Modified residue3421Phosphoserine By similarity
Modified residue3431Phosphoserine By similarity
Modified residue3471Phosphoserine By similarity
Modified residue3491Phosphoserine By similarity
Modified residue3811Phosphoserine Ref.9 Ref.10 Ref.12 Ref.15
Modified residue3941Phosphothreonine Ref.10
Modified residue4131Phosphoserine By similarity
Modified residue4141Phosphoserine By similarity
Modified residue4171Phosphoserine By similarity
Modified residue4191Phosphoserine By similarity
Modified residue4301Phosphoserine By similarity
Modified residue4461Phosphoserine Ref.7 Ref.9 Ref.10
Modified residue4751Phosphoserine Ref.7
Modified residue4771Phosphoserine Ref.7
Modified residue4781Phosphoserine Ref.7
Modified residue4791Phosphoserine Ref.7
Modified residue4821Phosphoserine Ref.7
Modified residue4841Phosphoserine Ref.7
Modified residue5031Phosphoserine Ref.15
Modified residue5451Phosphoserine By similarity
Modified residue5471Phosphoserine By similarity
Modified residue5481Phosphoserine By similarity
Modified residue5491Phosphoserine By similarity
Modified residue5811Phosphothreonine Ref.15
Modified residue5821Phosphoserine Ref.9 Ref.12
Modified residue5831Phosphoserine Ref.9 Ref.10 Ref.12 Ref.15
Modified residue6081Phosphoserine Ref.7
Modified residue6101Phosphoserine Ref.7
Modified residue6111Phosphoserine Ref.7
Modified residue6141Phosphoserine Ref.7
Modified residue6151Phosphoserine Ref.7
Modified residue6171Phosphoserine Ref.7
Modified residue6201Phosphoserine Ref.7
Modified residue6791Phosphoserine By similarity
Modified residue6861Phosphothreonine By similarity
Modified residue6931Phosphoserine By similarity
Modified residue6941Phosphoserine By similarity
Modified residue6951Phosphoserine By similarity
Modified residue7621Phosphoserine Ref.15
Modified residue7641Phosphoserine Ref.10 Ref.15
Modified residue7651Phosphoserine Ref.15
Modified residue7691Phosphoserine Ref.15
Modified residue7711Phosphoserine Ref.15
Modified residue7771Phosphoserine Ref.15
Modified residue7841Phosphoserine Ref.10
Modified residue8011Phosphoserine Ref.10
Modified residue8051Phosphothreonine Ref.10
Modified residue8681Phosphoserine Ref.7 Ref.15
Modified residue8701Phosphoserine Ref.7 Ref.15
Modified residue8711Phosphoserine Ref.7 Ref.15
Modified residue8751Phosphoserine Ref.7 Ref.15
Modified residue8771Phosphoserine Ref.7 Ref.15
Modified residue9061Phosphoserine Ref.7 Ref.9 Ref.10 Ref.13 Ref.14 Ref.15
Modified residue9141Phosphothreonine Ref.9
Modified residue9321Phosphoserine Ref.7
Modified residue9341Phosphoserine Ref.7
Modified residue9351Phosphoserine Ref.7
Modified residue9361Phosphoserine Ref.7
Modified residue9391Phosphoserine Ref.7
Modified residue9411Phosphoserine Ref.7
Modified residue9671Phosphoserine Ref.6 Ref.13
Modified residue9831Phosphothreonine Ref.13
Modified residue9961Phosphoserine Ref.7 Ref.15
Modified residue9971Phosphoserine Ref.7 Ref.15
Modified residue9981Phosphoserine Ref.7 Ref.15
Modified residue9991Phosphoserine Ref.7 Ref.15
Modified residue10011Phosphoserine Ref.7 Ref.15
Modified residue11111Phosphoserine Ref.6 Ref.8 Ref.15
Modified residue11491Phosphoserine By similarity
Modified residue11501Phosphoserine By similarity
Modified residue11531Phosphoserine By similarity
Modified residue11541Phosphoserine By similarity
Modified residue11901Phosphoserine Ref.15
Modified residue11911Phosphoserine Ref.15
Modified residue12281Phosphoserine Ref.6 Ref.8 Ref.12 Ref.15
Modified residue12341Phosphothreonine Ref.15
Modified residue12571Phosphoserine Ref.7 Ref.10 Ref.15
Modified residue13501Phosphoserine Ref.7 Ref.9 Ref.10 Ref.14 Ref.15
Modified residue13581Phosphothreonine Ref.10 Ref.15
Modified residue13611Phosphoserine Ref.10
Modified residue13761Phosphoserine Ref.6 Ref.10 Ref.15
Modified residue13781Phosphoserine Ref.6 Ref.7 Ref.8 Ref.10 Ref.12 Ref.14 Ref.15
Modified residue14071Phosphoserine Ref.15
Modified residue14101Phosphoserine Ref.11 Ref.15
Modified residue14711Phosphoserine Ref.6 Ref.7

Natural variations

Alternative sequence214 – 29077Missing in isoform 2.
VSP_022295
Alternative sequence9531Q → QDSNSKPARSKTLAPAPPER NTEGSSESSEEELPLTQ in isoform 4.
VSP_022296
Alternative sequence954 – 9585VIKPP → DQESS in isoform 5.
VSP_023133
Alternative sequence959 – 1488530Missing in isoform 5.
VSP_023134
Alternative sequence11721L → LV in isoform 2 and isoform 3.
VSP_022297
Natural variant531W → R in TCS. Ref.16
VAR_005630
Natural variant2211A → P: dbSNP rs11541811.
VAR_057002
Natural variant5161P → L Ref.16
VAR_005631
Natural variant6651P → A: dbSNP rs2071240. Ref.5
VAR_029869
Natural variant8871A → V: dbSNP rs7713638. Ref.16 Ref.5
VAR_005632
Natural variant10301R → K in a colorectal cancer sample; somatic mutation. Ref.17
VAR_035666
Natural variant13901A → V: dbSNP rs15251. Ref.16
VAR_005633
Natural variant14321D → G Ref.16
VAR_005634

Experimental info

Sequence conflict13891K → Q in AAB40722. Ref.2

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 [UniParc].

Last modified January 9, 2007. Version 2.
Checksum: 0F2988F5D7B53D20

FASTA1,488152,104
        10         20         30         40         50         60 
MAEARKRREL LPLIYHHLLR AGYVRAAREV KEQSGQKCFL AQPVTLLDIY THWQQTSELG 

        70         80         90        100        110        120 
RKRKAEEDAA LQAKKTRVSD PISTSESSEE EEEAEAETAK ATPRLASTNS SVLGADLPSS 

       130        140        150        160        170        180 
MKEKAKAETE KAGKTGNSMP HPATGKTVAN LLSGKSPRKS AEPSANTTLV SETEEEGSVP 

       190        200        210        220        230        240 
AFGAAAKPGM VSAGQADSSS EDTSSSSDET DVEGKPSVKP AQVKASSVST KESPARKAAP 

       250        260        270        280        290        300 
APGKVGDVTP QVKGGALPPA KRAKKPEEES ESSEEGSESE EEAPAGTRSQ VKASEKILQV 

       310        320        330        340        350        360 
RAASAPAKGT PGKGATPAPP GKAGAVASQT KAGKPEEDSE SSSEESSDSE EETPAAKALL 

       370        380        390        400        410        420 
QAKASGKTSQ VGAASAPAKE SPRKGAAPAP PGKTGPAVAK AQAGKREEDS QSSSEESDSE 

       430        440        450        460        470        480 
EEAPAQAKPS GKAPQVRAAS APAKESPRKG AAPAPPRKTG PAAAQVQVGK QEEDSRSSSE 

       490        500        510        520        530        540 
ESDSDREALA AMNAAQVKPL GKSPQVKPAS TMGMGPLGKG AGPVPPGKVG PATPSAQVGK 

       550        560        570        580        590        600 
WEEDSESSSE ESSDSSDGEV PTAVAPAQEK SLGNILQAKP TSSPAKGPPQ KAGPVAVQVK 

       610        620        630        640        650        660 
AEKPMDNSES SEESSDSADS EEAPAAMTAA QAKPALKIPQ TKACPKKTNT TASAKVAPVR 

       670        680        690        700        710        720 
VGTQPPRKAG TATSPAGSSP AVAGGTQRPA EDSSSSEESD SEEEKTGLAV TVGQAKSVGK 

       730        740        750        760        770        780 
GLQVKAASVP VKGSLGQGTA PVLPGKTGPT VTQVKAEKQE DSESSEEESD SEEAAASPAQ 

       790        800        810        820        830        840 
VKTSVKKTQA KANPAAARAP SAKGTISAPG KVVTAAAQAK QRSPSKVKPP VRNPQNSTVL 

       850        860        870        880        890        900 
ARGPASVPSV GKAVATAAQA QTGPEEDSGS SEEESDSEEE AETLAQAKPS GKTHQIRAAL 

       910        920        930        940        950        960 
APAKESPRKG AAPTPPGKTG PSAAQAGKQD DSGSSSEESD SDGEAPAAVT SAQVIKPPLI 

       970        980        990       1000       1010       1020 
FVDPNRSPAG PAATPAQAQA ASTPRKARAS ESTARSSSSE SEDEDVIPAT QCLTPGIRTN 

      1030       1040       1050       1060       1070       1080 
VVTMPTAHPR IAPKASMAGA SSSKESSRIS DGKKQEGPAT QVSKKNPASL PLTQAALKVL 

      1090       1100       1110       1120       1130       1140 
AQKASEAQPP VARTQPSSGV DSAVGTLPAT SPQSTSVQAK GTNKLRKPKL PEVQQATKAP 

      1150       1160       1170       1180       1190       1200 
ESSDDSEDSS DSSSGSEEDG EGPQGAKSAH TLGPTPSRTE TLVEETAAES SEDDVVAPSQ 

      1210       1220       1230       1240       1250       1260 
SLLSGYMTPG LTPANSQASK ATPKLDSSPS VSSTLAAKDD PDGKQEAKPQ QAAGMLSPKT 

      1270       1280       1290       1300       1310       1320 
GGKEAASGTT PQKSRKPKKG AGNPQASTLA LQSNITQCLL GQPWPLNEAQ VQASVVKVLT 

      1330       1340       1350       1360       1370       1380 
ELLEQERKKV VDTTKESSRK GWESRKRKLS GDQPAARTPR SKKKKKLGAG EGGEASVSPE 

      1390       1400       1410       1420       1430       1440 
KTSTTSKGKA KRDKASGDVK EKKGKGSLGS QGAKDEPEEE LQKGMGTVEG GDQSNPKSKK 

      1450       1460       1470       1480 
EKKKSDKRKK DKEKKEKKKK AKKASTKDSE SPSQKKKKKK KKTAEQTV 

« Hide

Isoform 2.

Checksum: 2272B824079B9793
Show »

FASTA1,412144,412
Isoform 3.

Checksum: DB75118CCFD47E88
Show »

FASTA1,489152,203
Isoform 4.

Checksum: EADE2843720E4754
Show »

FASTA1,524155,927
Isoform 5.

Checksum: 0297EE84C414F4DF
Show »

FASTA95896,755

References

« Hide 'large scale' references
[1]"Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome."
Dixon J., Edwards S.J., Gladwin A.J., Dixon M.J., Loftus S.K., Bonner C.A., Koprivnikar K., Wasmuth J.J.
Nat. Genet. 12:130-136(1996) [PubMed: 8563749] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
[2]"Identification of the complete coding sequence and genomic organization of the Treacher Collins syndrome gene."
Dixon J., Edwards S.J., Anderson I., Brass A., Scambler P.J., Dixon M.J.
Genome Res. 7:223-234(1997) [PubMed: 9074926] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
[3]"TCOF1 gene encodes a putative nucleolar phosphoprotein that exhibits mutations in Treacher Collins syndrome throughout its coding region."
Wise C.A., Chiang L.C., Paznekas W.A., Sharma M., Musy M.M., Ashley J.A., Lovett M., Jabs E.W.
Proc. Natl. Acad. Sci. U.S.A. 94:3110-3115(1997) [PubMed: 9096354] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
[4]"Another face of the Treacher Collins syndrome (TCOF1) gene: identification of additional exons."
So R.B., Gonzales B., Henning D., Dixon J., Dixon M.J., Valdez B.C.
Gene 328:49-57(2004) [PubMed: 15019983] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING (ISOFORM 4).
[5]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 16-1188 (ISOFORM 3), VARIANTS ALA-665 AND VAL-887.
Tissue: Eye and Skin.
[6]"Large-scale characterization of HeLa cell nuclear phosphoproteins."
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-967; SER-1111; SER-1228; SER-1376; SER-1378 AND SER-1471, MASS SPECTROMETRY.
Tissue: Epithelium.
[7]"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.
Cell 127:635-648(2006) [PubMed: 17081983] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83; THR-84; SER-85; SER-87; SER-88; SER-164; SER-171; SER-233; SER-446; SER-475; SER-477; SER-478; SER-479; SER-482; SER-484; SER-608; SER-610; SER-611; SER-614; SER-615; SER-617; SER-620; SER-868; SER-870; SER-871; SER-875; SER-877 AND SER-906; SER-932; SER-934; SER-935; SER-936; SER-939; SER-941; SER-996; SER-997; SER-998; SER-999; SER-1001; SER-1257; SER-1350; SER-1378 AND SER-1471, MASS SPECTROMETRY.
Tissue: Epithelium.
[8]"A probability-based approach for high-throughput protein phosphorylation analysis and site localization."
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.
Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-249; SER-1111; SER-1228 AND SER-1378, MASS SPECTROMETRY.
Tissue: Epithelium.
[9]"Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.
J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156; SER-304; THR-310; THR-316; SER-381; SER-446; SER-582; SER-583; SER-906; THR-914 AND SER-1350, MASS SPECTROMETRY.
Tissue: Epithelium.
[10]"Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry."
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138; THR-144; SER-153; SER-160; SER-381; THR-394; SER-446; SER-583; SER-764; SER-784; SER-801; THR-805; SER-906; SER-1257; SER-1350; THR-1358; SER-1361; SER-1376 AND SER-1378, MASS SPECTROMETRY.
[11]"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage."
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.
Science 316:1160-1166(2007) [PubMed: 17525332] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1410, MASS SPECTROMETRY.
[12]"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.
Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153; SER-156; SER-381; SER-582; SER-583; SER-1228 AND SER-1378, MASS SPECTROMETRY.
[13]"Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis."
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III
J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-906; SER-967 AND THR-983, MASS SPECTROMETRY.
[14]"Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M.
Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-906; SER-1350 AND SER-1378, MASS SPECTROMETRY.
[15]"A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83; THR-84; SER-85; SER-87; SER-88; SER-153; SER-156; THR-249; THR-310; THR-316; SER-381; SER-503; THR-581; SER-583; SER-762; SER-764; SER-765; SER-769; SER-771; SER-777; SER-868; SER-870; SER-871; SER-875; SER-877; SER-906; SER-996; SER-997; SER-998; SER-999; SER-1001; SER-1111; SER-1190; SER-1191; SER-1228; THR-1234; SER-1257; SER-1350; THR-1358; SER-1376; SER-1378; SER-1407 AND SER-1410, MASS SPECTROMETRY.
[16]"The mutational spectrum in Treacher Collins syndrome reveals a predominance of mutations that create a premature-termination codon."
Edwards S.J., Gladwin A.J., Dixon M.J.
Am. J. Hum. Genet. 60:515-524(1997) [PubMed: 9042910] [Abstract]
Cited for: VARIANTS LEU-516; VAL-887; VAL-1390 AND GLY-1432, VARIANT TCS ARG-53.
[17]"The consensus coding sequences of human breast and colorectal cancers."
Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. expand/collapse author list , Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., Velculescu V.E.
Science 314:268-274(2006) [PubMed: 16959974] [Abstract]
Cited for: VARIANT [LARGE SCALE ANALYSIS] LYS-1030.
+Additional computationally mapped references.

Web resources

Cross-references

Sequence databases

U40847 mRNA. Translation: AAC50903.1.
U76366 mRNA. Translation: AAC51181.1.
U84664 expand/collapse EMBL AC list , U84640, U84641, U84642, U84643, U84644, U84645, U84646, U84647, U84648, U84649, U84650, U84651, U84652, U84653, U84654, U84655, U84656, U84657, U84658, U84659, U84660, U84661, U84662, U84663 Genomic DNA. Translation: AAC51185.1.
U79659 expand/collapse EMBL AC list , U79645, U79646, U79647, U79648, U79649, U79650, U79651, U79652, U79653, U79654, U79655, U79656, U79657, U79658 Genomic DNA. Translation: AAB40722.1.
AY460334 mRNA. Translation: AAR87774.1.
BC011764 mRNA. Translation: AAH11764.1.
BC014559 mRNA. Translation: AAH14559.1.
BC027252 mRNA. Translation: AAH27252.1.
BC033093 mRNA. Translation: AAH33093.1.
IPIIPI00298696.
IPI00555853.
IPI00815713.
IPI00815731.
IPI00815944.
RefSeqNP_000347.2.
NP_001008657.1.
NP_001128715.1.
NP_001128717.1.
UniGeneHs.519672
Hs.605019

3D structure databases

ModBaseSearch...

Protein-protein interaction databases

IntActQ13428. 5 interactions.

PTM databases

PhosphoSiteQ13428.

Proteomic databases

PRIDEQ13428.

Genome annotation databases

EnsemblENSG00000070814. Homo sapiens. [Contig view]
GeneID6949.
UCSCuc003lrw.1. human.
uc003lry.1. human.
uc003lsa.1. human.

Organism-specific databases

GeneCardsGC05P149717.
H-InvDBHIX0005313.
HGNCHGNC:11654. TCOF1.
MIM154500. phenotype.
606847. gene.
Orphanet861. Treacher-Collins syndrome.
PharmGKBPA36405.
GenAtlasSearch...

Phylogenomic databases

HOVERGENQ13428.

Gene expression databases

ArrayExpressQ13428.
BgeeQ13428.
CleanExHS_TCOF1.
GermOnlineENSG00000070814. Homo sapiens.

Family and domain databases

InterProIPR006594. LisH_dimerisation.
IPR003993. TCS_treacle.
IPR017859. TCS_treacle-like.
[Graphical view]
PfamPF03546. Treacle. 3 hits.
[Graphical view]
PRINTSPR01503. TREACLE.
SMARTSM00667. LisH. 1 hit.
[Graphical view]
PROSITEPS50896. LISH. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio27207.
PMAP-CutDBQ13428.
SOURCESearch...

Entry information

Entry nameTCOF_HUMAN
AccessionPrimary (citable) accession number: Q13428
Secondary accession number(s): Q6SC72 expand/collapse secondary AC list , Q7Z5W9, Q96A52, Q99408, Q99860
Entry history
Integrated into UniProtKB/Swiss-Prot: November 1, 1997
Last sequence update: January 9, 2007
Last modified: July 7, 2009
This is version 86 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)

Relevant documents

Human chromosome 5

Human chromosome 5: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents